Exclusive: Sam Altman quietly got $75M from the University of Michigan for a new venture capital fund earlier this year

Just a few months after the artificial-intelligence-powered chatbot ChatGPT went live, the CEO of OpenAI, Sam Altman, filed disclosure materials for a new venture capital fund.

That fund, his venture firm Hydrazine Capitals fourth fund, was launched in March, and sometime before the end of June got a check from one of Silicon Valleys more noteworthy limited partners, the University of Michigans $17.9 billion endowment, which has also invested directly in OpenAI and in OpenAIs corporate venture fund, according to public filings and documents obtained by Fortune via a Freedom of Information Act request.That check is the second investment the University of Michigan has made into Altmans venture capital firm.

The documents are notable for two reasons. First, they offer the first confirmation that Altmans personal venture firm is investing institutional capital in addition to his own or that of his brothers and friends. Second, they go to show that the CEO of one of the hottest AI companies around has been fundraising outside his day job.

We have a longstanding relationship with Sam and Hydrazine IV. Hydrazine IV is a small fund in which the University of Michigan is the only outside investor, and this is an extension of our ongoing investment strategies, Dan Feder, senior managing director of investments at the University of Michigans endowment, told Fortune. Its unclear the funds exact size or focus. Feder, OpenAI, Altman, and Hydrazine declined to share more details of the fund or didnt respond to requests for comment.

In a statement to Fortune, an OpenAI spokeswoman said that Altman is fully focused on his role as CEO of OpenAI and spends only a small fraction of his time investing. He maintains transparency with the board about his occasional investments and adheres to a process for managing potential conflicts of interest.

The University of Michigan, which over the years has collectively invested billions into funds including those managed by Sequoia Capital, Andreessen Horowitz, Accel, General Catalyst, and Y Combinator, has written two of its largest-ever venture capital fund checks into Hydrazine funds: a $105 million check into Hydrazines second fund and, most recently, the $75 million into Hydrazines fourth fund, according to a list of all the endowments venture capital fund investments that was provided to Fortune. The endowment has also invested $18.7 million in an investment vehicle called Apollo Projects that Altman and his brothers set up a few years ago, records show. Altman is listed as director on all of the Hydrazine funds disclosure documents.

Comparatively, the endowment has written a $62 million check into General Catalyst Group IX, a nearly $1.4 billion fund, according to endowment records; a $50 million check into 8VC Fund V, a $880 million fund; and a $15.3 million check into Andreessen Horowitz Fund V, a $1.5 billion fund. A review of the endowments venture capital investment history found that the endowment rarely writes individual checks over $50 million to individual venture capital funds, although it has done so a handful of times to firms including Y Combinator, Chengwei Evergreen Capital, and Eclipse Ventures.

Altmans individual venture investments surfacedas an item of speculationlast month amid Altmans sudden termination, then later reinstatement, at OpenAI in November.Initially, OpenAIs boardclaimedthat Altman was not consistently candid with the board.

Altman this summer addressed his personal investing in an interview with The Information, saying he is mindful of conflicts of interest that may arise from his investments. Generally, I think the approach to conflict of interest is just avoid things that are directly an issue with the company youre running and disclose everything, Altman said at the time.

Altman, a former president of Silicon Valley incubator Y Combinator before he started running OpenAI full-time, has been an investor for a long time. He set up Hydrazine Capital in 2012 with his brother and the cofounder and CEO of Lattice, Jack Altman, though its unclear whether Jack Altman is still an investor. Partner Ryan Cohen is also an investor at Hydrazine and Apollo Projects, according to LinkedIn. He did not respond to a request for comment.

Do you have an insight to share? Got a tip? Contact Jessica Mathews atjessica.mathews@fortune.comor through the secure messaging app Signal at 479-715-9553.

Clarification, Dec. 19, 2023: An earlier version of this story referred to registration materials, rather than disclosure materials.

2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice| Do Not Sell/Share My Personal Information| Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.